PubMed Health⌕ Search

PubMed · 6804523

Renal transitional cell carcinoma: sonographic and pathologic correlation.

Abstract

Sonography was utilized to assess six patients with renal transitional cell carcinoma and was correlated with gross pathology in five cases. The neoplasms were seen as discrete, solid masses causing separation of the central renal sinus echoes. The echogenicity of the tumors and the renal parenchyma was similar, but the neoplasms were separated from the renal parenchyma by a linear echogenic zone of renal sinus fat. Pelvicaliceal blood clots, when markedly echogenic, could be differentiated from transitional cell carcinomas. Sonography contributed most in evaluating unilateral nonvisualized kidney or in the presence of nonfilling of the affected pelvicalices on excretory urography.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B R Subramanyam, B N Raghavendra, M R Madamba. Renal transitional cell carcinoma: sonographic and pathologic correlation.. https://doi.org/10.1002/jcu.1870100501

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Trimodality treatment and selective organ preservation for bladder cancer.

Standard treatment for muscle-invasive bladder cancer is cystectomy. Trimodality treatment, including transurethral resection of the bladder tumor (TURBT), radiation therapy and chemotherapy, has been shown to produce survival rates comparable to those of cystectomy. With these programs, cystectomy has been reserved for patients with incomplete response or local relapse. During the past 15 years, organ preservation by trimodality treatment has been investigated in prospective series from single centers and cooperative groups, with more than 1,000 patients included. Five-year overall survival rates in the range of 50% to 60% have been reported, and approximately three quarters of the surviving patients maintained their bladder. Clinical criteria helpful in determining ideal patients for bladder preservation include early tumor stage (including high-risk T1 disease), a visibly complete TURBT, and absence of ureteral obstruction. Close coordination among all disciplines is required to achieve optimal results. Future investigations will focus on (1) optimizing radiation techniques and incorporating more effective systemic chemotherapy, and (2) the proper selection of patients based on molecular makers.

Carcinoma, Transitional Cell↗